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Background: Lou Gehrig’s disease is accompanied by misfolding and aggregation of proteins.
Results: The intramolecular reactivity of cysteines of superoxide dismutase 1 results in new disulfide bonds in unusual positions.
Conclusion: Thiol/disulfide exchange reactions are altered in mutated proteins.
Significance: Intramolecular reorganization of disulfides may be one of the mechanisms of protein misfolding related to
neurodegenerative diseases.
Neurodegenerative diseases share a common characteristic,
the presence of intracellular or extracellular deposits of protein
aggregates in nervous tissues. Amyotrophic Lateral Sclerosis
(ALS) is a severe and fatal neurodegenerative disorder, which
affects preferentially motoneurons. Changes in the redox state
of superoxide dismutase 1 (SOD1) are associated with the onset
and development of familial forms of ALS. In human SOD1
(hSOD1), a conserved disulfide bond and two free cysteine res-
idues can engage in anomalous thiol/disulfide exchange result-
ing in non-native disulfides, a hallmark of ALS that is related to
protein misfolding and aggregation. Because of the many com-
peting reaction pathways, traditional bulk techniques fall short
at quantifying individual thiol/disulfide exchange reactions.
Here, we adapt recently developed single-bond chemistry tech-
niques to study individual disulfide isomerization reactions in
hSOD1. Mechanical unfolding of hSOD1 leads to the formation
of a polypeptide loop held by the disulfide. This loop behaves as
a molecular jump rope that brings reactive Cys-111 close to the
disulfide. Using force-clamp spectroscopy, we monitor nucleo-
philic attack of Cys-111 at either sulfur of the disulfide and
determine the selectivity of the reaction. Disease-causing muta-
tions G93A and A4V show greatly altered reactivity patterns,
which may contribute to the progression of familial ALS.
Amyotrophic Lateral Sclerosis (ALS)5 is a fatal neurodegen-
erative disease that causes progressive paralysis and death
within 3–5 years of diagnosis (1). Many familial cases of ALS are
linked to any of the more than 150 described mutations in the
superoxide dismutase 1 (SOD1) gene (2). However, the mecha-
nisms by which apparently unrelated mutations in SOD1 lead to
the same lethal phenotype remain unknown. The effects of the
mutations in the stability and catalytic activity of SOD1 are heter-
ogeneous (3–5). Indeed, the lethality of mutated enzymes has been
proposed to arise from the gain of a toxic function, rather than loss
of function (6, 7). This idea is strengthened by the fact that SOD1
knock-out mice do not develop symptoms of the disease (8).
SOD1 is a redox-active enzyme that catalyzes the dispropor-
tionation of two molecules of superoxide anion (O2
. ) into O2
and H2O2. Human SOD1 (hSOD1) is a homodimer in which
each subunit is composed of eight antiparallel beta strands
zipped by hydrogen bonds and building up a Greek key motif
(9). hSOD1 contains four cysteines at positions 6, 57, 111, and
146 (Fig. 1A). A conserved disulfide bond between Cys-57 and
Cys-146 determines a structural loop that contains more than
one-half of the molecule (Fig. 1, A and B). The presence of
Cys-111 in this loop (Fig. 1, A and B) is a unique hallmark of the
enzyme in primates, humans, and chicken (10).
Formation of insoluble aggregates containing SOD1 is a com-
mon pathophysiological characteristic of ALS (6, 11). Non-native
disulfide formation contributes to form and/or stabilize SOD1
aggregates that accompany progression of the disease (12–15).
Indeed, it has been suggested that scrambling of the disulfide and
the free cysteines in SOD1 results in formation of insoluble aggre-
gates (16). Interestingly, the free cysteines in SOD1, in particular
Cys-111, contribute to the toxicity of mutant forms of SOD1 (14,
17). However, little is known about how non-native disulfides
involving Cys-6 and Cys-111 are formed in vivo.
* This work was supported in whole or in part by National Institutes of Health
Grants HL66030 and HL61228 (to J. M. F.) and Grants SAF2011-28485 from
the Spanish Ministry of Economy and Competitiveness and European
Union FEDER PR2011-0339 from the Spanish Ministry of Education, and
Government of Catalonia SGR2009/152 (to C. S.).
1 To whom correspondence should be addressed: Laboratory of Cellular and
Molecular Neurobiology, Department of Pathology and Experimental
Therapeutics, Faculty of Medicine-Campus Bellvitge, University of Barce-
lona, Feixa Llarga s/n. Hospitalet de Llobregat, 08907 Barcelona, Spain. Tel.:
34-93-4024279; Fax: 34-93-4035810; E-mail: solsona@ub.edu.
2 Supported by the National Institutes of Health Training Program in Molec-
ular Biophysics (T32GM008281).
3 Recipient of Grant SAF2011-27566, Spanish Ministry of Economy and Com-
petitiveness and European Union FEDER.
4 Supported by National Institutes of Health Grant AI106072.
5 The abbreviations used are: ALS, amyotrophic lateral sclerosis; SOD, super-
oxide dismutase; AFM, atomic force microscopy.
THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 289, NO. 39, pp. 26722–26732, September 26, 2014
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc. Published in the U.S.A.
26722 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 289 • NUMBER 39 • SEPTEMBER 26, 2014
This is an open access article under the CC BY license.
Mitochondria are one of the main sources of misfolded
hSOD1 and a key cellular organelle to induce motoneuron death
(18). Albeit hSOD1 is preferentially cytosolic, it also reaches the
intermembrane space of mitochondria as an apoenzyme (19,
20). In this journey, hSOD1 is mechanically unfolded as it is
threaded through the TOM complex (21, 22). We have recently
shown that mechanical unfolding of proteins can result in the
exposure of reactive cysteines, which then can engage in redox
reactions (23–25). Similarly, cysteines in hSOD1 are exposed to
the solution as the protein is translocated into the intermem-
brane space of mitochondria, resulting in a much enhanced
reactivity that could lead to formation of non-native disulfides.
Remarkably, the mitochondrial fraction of the spinal cord of
mutant SOD transgenic mice has been shown to contain
insoluble SOD1 multimers that are crosslinked via disulfide
bonds (26).
Although key to the interplay between thiol biochemistry
and hSOD1 aggregation, the reactivity of the cysteines in
hSOD1 remains poorly understood. Classic biochemistry tech-
niques are of limited value to study reversible chemical reac-
tions that involve several competing pathways, such as those
originating from the four cysteines of hSOD1. In this report, we
use recently developed single-molecule atomic force micros-
copy (AFM) techniques (23) to monitor directly the reactivity of
Cys-111 toward the conserved disulfide in hSOD1, one of the
reactions that triggers disulfide rearrangement associated with
ALS. In our experiments, hSOD1 is unfolded mechanically to
probe the reactivity of its cysteine residues. In vivo, equivalent
reactions can be enabled during mitochondrial import or due to
thermal fluctuations that transiently unfold hSOD1 (27, 28).
We find that hSOD1 mutants that cause familial ALS show
altered reactivity. Hence, aberrant thiol/disulfide chemistry in
hSOD1 may influence the onset and progression of ALS.
EXPERIMENTAL PROCEDURES
Protein Purification—The expression and purification of
polyproteins I273-SOD-I273, I273-G93A-I273, and I273-A4V-
I273 were accomplished following standard protocols that have
been described elsewhere (23). The gene coding for hSOD1 was
a generous gift from Professor J.E. Esquerda, University of
FIGURE 1. Construction of AFM-ready polyproteins to study hSOD1. A, representation of a single monomer of hSOD1 (Protein Data Bank, accession number
2C9V). The N terminus (Nt) and the C terminus (Ct) are indicated. The four cysteine residues appear as yellow sticks and are labeled according to their position
in the sequence of hSOD1. Cys-57 and -146 form an intramolecular disulfide bond, which determines a loop containing Cys-111. The segment of the loop
between Cys-57 to Cys-111 is colored in blue, and the rest of the loop, up to Cys-146, is colored in green. For clarity in the representation, metal ions are not
shown. B, schematic representation of the loop defined by the disulfide in hSOD1. C, scheme of the polyprotein construct I273-SOD-I273. A single molecule of
hSOD1 (blue) is placed between six modules of I27 protein (yellow). In our experiments, single polyprotein molecules are attached between the AFM cantilever
and a gold-covered surface. Mechanical force is generated by retracting the gold-covered surface using a piezoelectric actuator. Mechanical response of the I27
protein domains fingerprints successful events where hSOD1 was subject to mechanical force. D, time-dependent superoxide generation by xanthine oxidase
(black circles). We measure activity of SOD from the inhibition of superoxide formation. Our reference is hSOD1 extracted from human erythrocytes (black
squares, 0.2 IU and black triangles 10 IU). Catalytic activity is conserved in polyproteins containing one molecule of hSOD1 WT (open circles), and also for the
mutants G93A (open squares) and A4V (open inverted triangles). Solid lines fit a single exponential function y0  Ae
(1/)x where y0 values range from 0.18 to 2.08;
A from 0.16 to 2.17 and 1/ from 0.05 to 0.34.
hSOD1 Disulfide Isomerization at the Single Molecule Level
SEPTEMBER 26, 2014 • VOLUME 289 • NUMBER 39 JOURNAL OF BIOLOGICAL CHEMISTRY 26723
Lleida (Spain). To obtain the mutations G93A and A4V, we
applied the QuikChange Multi Site-Directed Mutagenesis kit
from Stratagene (La Jolla, CA). We constructed polyproteins by
successive digestion and ligation of DNA fragments (29), (30).
BamHI and KpnI sites were used to insert cDNAs into the
expression vector pQE80L (Qiagen, Valencia, CA). Protein pro-
duction in Escherichia coli Origami B cells was induced at A600
1.0 with 1 mM isopropyl--D-thiogalactoside overnight at 23 °C.
SOD polyproteins were purified from the soluble fraction after
sonication and two passes through a French press. We employed
His-tag affinity chromatography using Talon resin (Mountain
View, CA), followed by chromatography using a Superdex 200
column (Amersham Biosciences, Pittsburgh, PA) in HE buffer
(10 mM HEPES, 150 mM NaCl, 1 mM EDTA, pH 7.2) or H buffer
(10 mM HEPES, 150 mM NaCl, pH 7.2), which lacks EDTA. We
did not observe any difference between proteins purified with
or without EDTA in our experimental results, due to the metal
ions being tightly chelated by the enzyme. Indeed, very harsh
conditions are required to remove the metal ions from the
enzyme (see below) (31).
Single Molecule Force Clamp Spectroscopy—Force spectros-
copy experiments were done as previously reported (23). In
summary, aliquots (1–10 l) of a solution of polyproteins I273-
SOD-I273, I273-G93A-I273, or I273-A4V-I273 (0.2 mg/ml, in
HE or H buffer) were deposited onto a gold coverslip for 1 to 3
min before adding degassed H buffer with varying concentra-
tion of TCEP. We used the equipartition theorem to calibrate
silicon nitride cantilevers (MLCT, Bruker, Camarillo, CA) (32).
Measured spring constants were typically in the 14 –19 pN
nm1 range. To pick up single polyproteins, the cantilever was
pressed against the gold surface containing the polyproteins at
contact forces of 2 nN for 1–2 s. Then, the piezo actuator was
retracted. If a tether was established, we ramped the force
between 0 and 250 pN during 5 s and then force was kept at 250
pN for 20 s or until the tether broke. We used a custom built
AFM set-up that uses electronic feedback to control the force
with a 5-ms response time (32, 33). Experiments were done at
room temperature (22–23 °C) in a fluid cell filled with addi-
tional H buffer with TCEP. To assure that SOD1 molecules had
been subject to mechanical force, we only analyzed traces con-
taining between four and six 25 nm steps, corresponding to the
unfolding of I27 modules. We measured the size of all the steps
that were detected after the first step due to I27 unfolding or
after the partially unfolded hSOD1 (see Fig. 3, A–C). For sim-
plicity, in the final histograms we did not include the steps due
to the unfolding of I27 modules. The data points and the error
bars (S.E.) in Fig. 6B were estimated by bootstrapping (34), (35).
To this end, several thousand artificial data sets were generated
randomly from the experimentally observed reaction pathways.
The frequency of each pathway was calculated for every data
set, which allowed us to obtain a distribution of frequencies.
The mean and the standard deviation of such distributions are
reported in Fig. 6B.
Kinetic Analysis—In the presence of TCEP, disulfide 57–146
can be cleaved following three competing reaction pathways
(Fig. 6A). The frequencies of appearance of the three pathways
are given by Equations 1–3,
fA 
k1








k1  k2  k3  TCEP
(Eq. 3)
where k1, k2, and k3 are the corresponding rate constants. Since
f(A)  f(B)  f(C)  1, we can rewrite f(C) as (1  a)/(a 
[TCEP]) where a  (k1  k2)/k3. We fitted the experimental
data to this expression to obtain the value a for hSOD1 WT
(1519 	 264 M) and G93A (559 	 147 M) (Fig. 6B, red lines).
Considering the regioselectivity of the intramolecular reaction,
b  k1/(k1k2), we can rewrite f(A)  ba/(a  [TCEP]) and
f(B)  (1  b)a/(a  [TCEP]). Regioselectivity was calculated
from the number of events observed for each reaction pathway,
b  n(A)/(n(A)  n(B)), and errors were estimated by boot-
strapping (see above). We used the experimentally determined
regioselectivities to plot f(A) and f(B) in Fig. 6B for WT and
G93A proteins (green and blue lines).
Blocking of Cys-111 by Incubation with Maleimide—Follow-
ing adsorption to the gold-coated coverslips, the polyprotein
was incubated for 90 min with 250 mM maleimide freshly dis-
solved in Na-borate buffer, 50 mM, pH 8.5 (36). The preparation
was washed with H buffer, initially with no TCEP added and
finally recorded in the same solution in the presence of 2.5 mM
TCEP.
Preparation of the Apo Form of hSOD1—We followed a pro-
cedure adapted from McCord and Fridovich (31). After the
polyprotein was adsorbed to a gold coverslip, 5 l of a solution
of 100 mM Na-acetate buffer, 1 mM EDTA, pH 3.8 were added.
After incubation for at least 5 min, the sample was rinsed with
recording solution containing 2.5 mM TCEP.
Remetallation of the Apoenzyme—The apo form of hSOD1
prepared as above was rinsed with a solution containing 2.7 mM
CuSO4, 0.9 mM ZnCl2, 150 mM NaCl, Tris 50 mM, pH 6.8, and
then incubated in the same buffer for 30 min (31). Then, the
sample was rinsed with 10 mM Tris, pH 6.8, and finally washed
again with 150 mM NaCl, 10 mM HEPES, pH 7.2. Finally, 2.5 mM
TCEP was added before starting the AFM experiments.
Determination of Superoxide Dismutase Activity—SOD1 activ-
ity was measured using the assay of Enzo Life Sciences (Exeter,
UK). This system measures the coupled reaction between Xan-
thine Oxidase, which generates superoxide radical, and SOD,
which converts superoxide into water and peroxide. The super-
oxide anion reacts with the dye WST-1, which is converted to a
colored WST-1 formazan product that absorbs light at 450 nm.
SOD scavenges superoxide anion and thereby reduces the rate
of formation of WST-1 formazan product.
Western Blot—Standard SDS-PAGE was performed in
4 –20% acrylamide in Tris-glycine gels (Bio-Rad). Samples were
boiled for 5 min in sample buffer containing 5% -mercapto-
ethanol prior to electrophoresis. The fractionated proteins
were electrically transferred onto nitrocellulose membranes
using a semidry apparatus (Bio-Rad). The membranes were
stained with 0.2% Ponceau S and washed three times with dis-
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tilled water. Nonspecific binding was blocked by incubating
with 0.1% Tween 20 and 5% skimmed milk in PBS for 1 h. Then,
the membranes were incubated with sheep polyclonal antibody
against human SOD1 (Calbiochem, Darmstadt, Germany) at
dilution of 1:5000 in blocking solution overnight at 4 °C. Rabbit
anti-sheep-HRP secondary antibody, at dilution 1:2000 in
blocking solution 1 h at 37 °C, was used. The membranes were
washed three times in Tris-buffered saline containing 0.05%
Tween 20. Positive bands were detected using an enhanced
chemiluminescence system.
RESULTS
Disulfide 57–146 Is Buried in the Folded State of hSOD1—
Thiol/disulfide exchange reactions involving disulfide 57–146
and the free cysteines of hSOD1 have been proposed to contrib-
ute to aggregation and misfolding in ALS (15, 16, 26, 37–39).
However, description of these reactions at the molecular level is
still missing.
Since solvent accessibility determines the reactivity of disul-
fide bonds (40), we first examined the solvent accessibility of
disulfide 57–146 in hSOD1 using force-clamp spectroscopy.
When a protein is pulled using force clamp, its mechanical
unfolding generates step changes in the length of the polypep-
tide. The size of an unfolding step depends exclusively on the
number of amino acids that are released by force following pro-
tein unfolding (23). Disulfide bonds cannot be broken by forces
in the picoNewton (pN) range. Hence, if present in a protein, a
disulfide can be detected from the limited extension of the pro-
tein upon mechanical unfolding (40). We exploited this prop-
erty to determine whether disulfide 57–146 in hSOD1 is solvent
accessible and can be cleaved by incubation with reducing
agents.
To be able to study hSOD1 using force clamp, we engineered
and purified to homogeneity the polyprotein I273-SOD-I273
(Fig. 2). This chimeric protein consists of one hSOD1 domain
flanked by six I27 modules (Fig. 1C). Mechanical unfolding of
the I27 domains provides a mechanical fingerprint that identi-
fies successful single-molecule recordings (29, 41). SOD1-con-
taining polyproteins retain superoxide dismutase activity (Fig.
1D) implying that the functional fold of hSOD1 is preserved in
the polyprotein. Polyproteins containing ALS-linked muta-
tions G93A and A4V in hSOD1 also retain enzymatic activity
(Fig. 1D).
In our AFM experiments, we include 50 M-50 mM of the
reducing agent TCEP in the bathing solution. We apply a linear
increase in force from 0 to 250 pN to single I273-SOD-I273
polyproteins and then keep the force constant at 250 pN for up
to 20 s. This protocol triggers the unfolding and extension of
the I27 domains. I27 unfolding events are detected as step
changes in length of 25 nm (Fig. 3, A–C, black dots) (25). Given
the design of the I273-SOD-I273 polyprotein, we are certain
that hSOD1 has been subject to force in traces where at least
four I27 unfolding events are detected (Fig. 1C). We therefore
selected traces that showed four 25-nm steps and analyzed the
length of the remaining steps. We find four different popula-
tions of steps centered at 12, 19, 22, and 31 nm (Fig. 3D), which
arise from the mechanical unfolding of hSOD1 and the reactiv-
ity of its conserved disulfide bond, as explained below. These
populations of events do not depend on the nature of the reduc-
ing agent, since experiments in the presence of dithiothreitol
induce a very similar pattern of step lengths (Fig. 4).
Since the size of mechanical unfolding steps is determined by
the number of amino acids released to force, we could predict
the step size associated with the mechanical unfolding of
hSOD1, both in the reduced and oxidized states. If disulfide
57–146 was exposed, it would be reduced by TCEP before the
molecule is picked up by the cantilever (AFM experiments are
conducted over time scales of hours). In this scenario, all 153
amino acids should be extended after mechanical unfolding.
Considering that the distance between N and C termini of
folded hSOD1 is 0.9 nm, we predict that the mechanical unfold-
ing of reduced hSOD1 would result in a step size of 48.7–53.1
nm between 100 pN and 250 pN (23). In the alternative sce-
nario, disulfide 57–146 is buried, and therefore would remain
unreactive to TCEP. In this case, the disulfide bond would pre-
vent the unfolding of 89 amino acids and the step size associ-
ated with hSOD1 unfolding would be 20.5–22.4 nm between
100 pN and 250 pN. These values match the population of steps
at 22 nm in Fig. 3D (colored in gray). We do not detect a signif-
icant population of steps at 
50 nm that would be compatible
with the mechanical unfolding of reduced hSOD1, indicating
that disulfide 57–146 remains buried in the fold of hSOD1
and therefore unreactive. The 22 nm step appears in 9.3% of the
traces, and mostly at low forces (gray dots in Fig. 3, A and B). In
the remaining traces, unfolding of hSOD1 probably occurs at a
force below our detection limit. As explained in the next sec-
tion, the other populations of steps in Fig. 3D are the result of
chemical reactions involving disulfide 57–146. These reactions
are triggered by mechanical unfolding of hSOD1, which gives
further support to our conclusion that disulfide 57–146 is bur-
ied and unreactive in the folded structure of hSOD1.
Detection of Thiol/Disulfide Exchanges from the Length Sig-
nature of the Reactions—Mechanical unfolding of hSOD1
induces the formation of a polypeptide loop containing Cys-
111, which is held by disulfide 57–146 (Fig. 1B). We have shown
before that an equivalent loop behaves as a molecular “jump
FIGURE 2. Western blot of polyproteins containing SOD1. Western blot of
polyprotein I273-SOD-I273 containing a monomer of wild type hSOD1 (WT), or
mutants G93A or A4V. In the left panel the membrane was stained with Pon-
ceau S. Bands correspond to the expected mobility of six subunits of I27 and
one molecule of hSOD1. In the right panel, membrane was stained using a
polyclonal antibody against hSOD1.
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rope” where the free cysteine remains close to the disulfide,
enabling intramolecular reactions between the cysteine and the
disulfide (23). We took advantage of this configuration to study
the reactivity of Cys-111 against the conserved disulfide in
hSOD1 (Figs. 3, 5, and 6).
In our experiments, the intramolecular reactions compete
with the intermolecular cleavage of the disulfide by TCEP, for a
total of three competing reactions (Fig. 6A). Since the segments
of the loop delimited by Cys-111 have different lengths, it is
possible to distinguish unambiguously the three reaction path-
hSOD1 Disulfide Isomerization at the Single Molecule Level
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ways. The cleavage of disulfide 57–146 by TCEP releases 89
amino acids, which corresponds to an increase in length of 30.7
nm at 250 pN (23). This value corresponds to one of the popu-
lations in the length histogram (Fig. 3D, red, see Fig. 3A for an
example trace). The intramolecular attack of Cys-111 on the
disulfide at position 57 frees 35 amino for a theoretical exten-
sion of 12.3 nm; whereas the alternative intramolecular reac-
tion involving position 146 is predicted to generate a step of 19
nm (Fig. 6A). Both sizes match the remaining two populations
of steps in Fig. 3D (blue and green).
Intramolecular reaction between Cys-111 and disulfide
57–146 triggers the formation of new disulfides between Cys-
111 and Cys-57 or Cys-146. Such newly formed disulfides can
FIGURE 3. Mechanical unfolding exposes disulfide 57–146 enabling reduction by TCEP. Mechanical unfolding of hSOD1 and cleavage of its disulfide bond
were monitored using force-clamp spectroscopy. Single I273-SOD-I273 polyproteins were initially subject to a linear increase in force from 0 to 250 pN at 50
pN/s, and then force was held constant at 250 pN. The recordings presented in all panels were obtained in a solution containing 2.5 mM TCEP. Mechanical force
triggers mechanical unfolding of the protein modules in the polyprotein. I27 acts as a fingerprint protein that allows us to select traces where hSOD1 has been
subjected to force. Mechanical unfolding of hSOD1 renders the disulfide accessible to TCEP, and enables thiol/disulfide exchange reactions involving the
disulfide in hSOD1. In panels A, B, and C, the lower trace shows the force pulse, while the upper traces correspond to the length of the polyprotein. Each I27
unfolding event produces a 25-nm step (black dots). Occasionally, we detect unfolding of hSOD1 at low forces (marked by gray dots). An example of each one
of the three patterns of steps that we found is shown in A through C. A, after extending the six I27 modules, an additional extension of 31 nm (red) is observed;
B, after the extension of six I27 modules, two additional steps of 19 nm (blue) and 12 nm (green) are detected; C, the 12-nm step appears before the 19-nm step.
D, distribution of step sizes induced by the mechanical extension of I273-SOD-I273 in the presence of TCEP. To build the histogram, we pooled results obtained
at different concentrations of TCEP. We did not include in the histogram steps of 25 nm coming from the extension of I27 modules. The distribution reveals four
peaks centered at: 12 nm (green), 19 nm (blue), 22 nm (gray), and 31 nm (red). The rest of the steps recorded. which could not be assigned and probably
represent nonspecific interactions, are shown in white. n  871 events.
FIGURE 4. Effects of concentration and different reducing agents on thiol/
disulfide exchange reactions in hSOD1. Distribution of step sizes found at
0.05 mM TCEP (n  66), 1.5 mM TCEP (n  95), and 20 mM DTT (n  89).
FIGURE 5. Distribution of step sizes at different concentrations of TCEP.
The amplitude of peaks (A, 12 nm; B, 19 nm; C, 31 nm) varies according to the
concentration of TCEP. At low concentrations of TCEP (0.25 mM), peaks cen-
tered at 12 and 19 nm predominate over the peak at 31 nm, as the intramo-
lecular reaction of Cys-111 with the disulfide dominates over the intermolec-
ular cleavage of the disulfide by TCEP. At high TCEP concentrations, the peak
at 31 nm is higher than peaks at 12 and 19 nm (data obtained from n  165
upper panel, n  115, middle panel, n  67 lower panel). The population of
events coming from the unfolding of hSOD1 is colored in gray.
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be cleaved by TCEP reaching a fully extended polypeptide,
which is detected as a final step in our recordings. In Fig. 3B, a
trace is presented where the initial reaction of Cys-111 on Cys-
146 generates a step of 19 nm, which is followed by cleavage of
disulfide 111–146 producing a step of 12 nm. In Fig. 3C, a trace
is shown where Cys-111 attacks the disulfide at position 57 (12
nm). Subsequent reduction of disulfide 57–111 is accompanied
by a final 19-nm step. Hence, using force-clamp we can unam-
biguously identify individual thiol/disulfide exchanges involv-
ing Cys-111 and the conserved disulfide in hSOD1.
Regioselectivity and Competition between Inter- and Intra-
molecular Reactions—Inter- and intramolecular reaction path-
ways are mutually exclusive and therefore in competition (Fig.
6A). We never observed steps of 31 nm (reporting on intermo-
lecular reduction of the disulfide) and 12/19 nm (reporting on
intramolecular reactions) in the same single-molecule trace,
which is in agreement with our assignment of step sizes. To
further test the validity of our model, we compared the distri-
bution of step sizes obtained at increasing concentrations of
TCEP. Since the rate of intermolecular attack of TCEP depends
on the concentration of TCEP, while the rate of intramolecular
reactions is independent of the concentration of TCEP, we pre-
dicted that the intermolecular pathway would be favored at
high concentrations of the reducing agent. Results showed that
at low TCEP concentrations, the steps reporting on intramo-
lecular pathways are dominant (12 and 19 nm steps, Fig. 5). In
contrast, the intermolecular pathway is favored at higher con-
centrations of TCEP (31 nm steps, Fig. 5). Hence, our results are
in agreement with the kinetic model in Fig. 6A.
Using both the size of the steps and their order of appearance,
we could assign unambiguously experimental traces to one of
the three possible reaction pathways to cleave disulfide 57–146.
Fig. 6B represents the frequency of each pathway of disulfide
reduction at different concentrations of TCEP, with solid lines
representing fits to the experimental data using the kinetic
model in Fig. 6A (“Experimental Procedures”). Results in Fig.
6B confirm that the intermolecular attack by TCEP is favored at
higher concentrations of reducing agent. Also, we detect that
the frequency of pathway A (green) is slightly lower than that of
pathway B (blue). Pooling together all experimental traces, we
conclude that nucleophilic attack of Cys-111 at position 146 is
1.3 times more frequent than attack on position 57 (n  168) in
wild-type hSOD1.
Disease-linked Variants of hSOD1 Show Altered Reactivity
Patterns—Since aberrant thiol/disulfide exchange reactions
involving hSOD1 have been proposed to occur in ALS (14, 16,
42–50), we applied our single-molecule methods to study the
reactivity of Cys-111 and the conserved disulfide 57–146 in
diseased-linked forms of hSOD1. We concentrated our efforts
in hSOD1 G93A, which was used to produce a widely employed
transgenic mice model of ALS (51) and hSOD1 A4V, which is
the most prevalent mutation associated with ALS in North
America (52).
The regioselectivity of disulfide isomerization in hSOD1
G93A is greatly increased (Fig. 6B). In this mutant, the attack at
position 146 is 3.2 times more frequent than at position 57 (n 
55), a 2.5-fold increase with respect to the wild-type protein. To
investigate whether the mutation G93A is accompanied by a
decrease in the overall reactivity of Cys-111, we calculated the
ratio k2/k3  a(1  b) (see “Experimental Procedures”) as a
measure of the propensity of Cys-111 to attack Cys-146. For
WT, we obtained k2/k3  869  162 M, while the value for the
G93A mutant is k2/k3  427  117 M. Hence, our results show
that mutation G93A both decreases the overall reactivity of
Cys-111, and biases the intramolecular reactivity toward the
attack on position 146. These effects could be explained by two
non-exclusive mechanisms. First, the mutation could induce
structural perturbations that result in alterations of the chem-
ical environment of Cys-111. In this regard, it has been shown
that mutation G93A leads to noticeable changes in the struc-
ture and dynamics of hSOD1 (53, 54). In addition, the mutation
may render Cys-111 more sensitive to oxidation (47, 48), which
would make Cys-111 unreactive. Indeed, equivalent loss of
reactivity of Cys-111 can be reproduced in hSOD1 WT by pre-
incubation with maleimide, an alkylating agent that targets free,
accessible thiols (Fig. 7, A and B).
FIGURE 6. The intramolecular isomerization of the disulfide bond of hSOD1 competes with intermolecular reduction by TCEP. A, scheme of available
reaction pathways. Pathway A: the attack of Cys-111 on Cys-57 results in a new disulfide bond between Cys-57 and Cys-111, releasing 35 amino acids (12-nm
step). Pathway B: the attack of Cys-111 on Cys-146 forms a new disulfide bond between Cys-146 and Cys-111, releasing 54 amino acids (19-nm step). Pathway
C: the disulfide bond is cleaved by TCEP releasing 89 amino acids (31 nm step). Notice that in pathways A and B the disulfide bond between Cys-111 and Cys-57,
or Cys-111 and Cys-146, is eventually attacked by TCEP producing an additional step of 19 or 12 nm. k1, k2, and k3 represent the rate constants associated with
each pathway. B, frequencies of the different reaction pathways at different TCEP concentrations; the first step after the fingerprint reveals the reaction
pathway that accounts for the cleavage of the disulfide bond. Green squares correspond to step size of 12 nm (pathway A), blue triangles to 19 nm steps
(pathway B), and red circles to 31 nm steps (pathway C). Left panel: frequencies in wild type SOD1 construct, n  45. Right panel: frequencies in the G93A mutant,
n  24. Solid lines were obtained using the kinetic model described in “Experimental Procedures.”
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Mutation A4V abolishes the pattern of step sizes observed
for the wild-type protein, with no clear populations of steps
(Fig. 7C). We propose that in hSOD1 A4V the disulfide bond is
exposed to the solvent, making it sensitive to reduction by
TCEP before the molecule is picked up by the AFM cantilever.
Since there would be no disulfide by the time the mutant pro-
tein is pulled, no steps involving reactivity of the disulfide bond
can be detected. It has been proposed that structural disorder in
metal-free (apo) hSOD1 proteins leads to an increased reactiv-
ity of the disulfide bond, probably arising from higher exposure
to the solvent (55). We found that apo hSOD1, as the A4V
mutant, does not show steps that can be assigned to reactions
involving the disulfide (Fig. 7D). This result supports the
hypothesis that structural destabilization of hSOD1 A4V leads
to the exposure of the disulfide, which can be easily reduced by
the TCEP in the solution. The absence of a population of events
reporting on the mechanical unfolding of apo hSOD1 or the
A4V mutant, which would be expected at 
50 nm if no disul-
fide bond is present (see above), supports the idea that the apo
enzyme and the mutant A4V are significantly destabilized and
they unfold at forces below our detection limit. In 15 out of 21
traces in which the apoenzyme was remetalized with Cu2 and
Zn2, the steps due to the disulfide bond reduction were recov-
ered (Fig. 8), indicating that exposure of the disulfide bond in
apo hSOD1 is reversible upon incorporation of Cu2 and Zn2.
DISCUSSION
The presence of disulfide bonds in cytosolic proteins, such as
SOD1, is rather uncommon (9). Our single-molecule data show
that hSOD1 is able to maintain the disulfide bond in a highly
reducing environment. This property is probably important for
the stability of the protein in the cytosol, since the reduction of
the disulfide induces misfolding of parts of the molecule (42).
Interestingly, hSOD1 contains free cysteine residues that can
cleave the disulfide triggering disulfide isomerization reactions.
Disulfide isomerization may lead to disulfide cross-linked
hSOD1 aggregates, which have been detected in spinal cords of
model ALS mice (12). Indeed, these abnormal configurations
have been implicated in the gain of toxic function of hSOD1 (13,
14, 47). In order to examine thiol/disulfide exchange reactions
that are involved in the aggregation of hSOD1, there is a need to
develop reliable assays that can probe directly the reactivity of
the cysteines in hSOD1.
We applied single-molecule methods using force clamp
AFM spectroscopy (34, 56) to study the effect of disease-linked
mutations in the reactivity of Cys-111 and the conserved disul-
fide of hSOD1. In our assay, hSOD1-containing polyproteins
are stretched using an AFM cantilever. The resulting pulling
force triggers the unfolding of the hSOD1 molecule, exposing
the disulfide to the bathing solution. In the presence of reducing
agents, we monitored the intermolecular reduction of the disul-
fide in competition with intramolecular disulfide isomerization
reactions mediated by Cys-111.
FIGURE 7. Effects of mutations G93A and A4V on thiol/disulfide exchange reactions in hSOD1. Distribution of step sizes induced by the mechanical
extension of I273-SOD-I273 in the presence of 2.5 mM TCEP for different protein preparations. Colors and nomenclature are the same as in Fig. 3. A, for mutant
G93A, the intramolecular pathways A and B are less populated than for the wild-type protein (n  96). B, the lack of reactivity of Cys-111 can be reproduced in
wild-type hSOD1 by pre-incubation with the thiol alkylating agent maleimide (n  69). C, for mutant A4V, the steps reporting on the reduction/isomerization
of the disulfide bond are rare, suggesting that the disulfide bond in hSOD1 A4V is accessible to TCEP in solution (n  111). D, similar results were obtained with
apo hSOD1 (n  51).
FIGURE 8. Recovery of the intramolecular disulfide bond after remetaliz-
ing apo hSOD1. The polyprotein I273SODI273 was treated to remove the
metals and then incubated with solutions containing Cu2 and Zn2 to rein-
troduce these metals in hSOD1. Cleavage of the disulfide bond could be
detected in pulling experiments in the presence of TCEP. Black dots indicate
the unfolding of the six I27 modules, whereas the gray dot marks the unfold-
ing of hSOD1 up to the disulfide bond. Red arrowhead indicates the rupture of
disulfide bond 57–146, rendering a step of 31 nm.
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Cys-111 is only present in SOD from primates and its role in
ALS pathophysiology has been extensively investigated. Cys-
111 binds Cu2 during the biosynthesis of SOD1 (10) and con-
tributes to keep this metal in the correct position (57). Cys-111
is placed on the surface of the molecule where it can be oxidized
changing the conformation of the wild type molecule in a way
similar to several point mutations (58). In addition, Cys-111
reacts with sulfide (59), and can bridge the two molecules of the
homodimer through a polysulfane moiety (60). Hence, Cys-111
appears to function as an antenna sensitive to the redox envi-
ronment, and has been related to aggregation of mutant forms
of SOD1. For instance, glutathionylation of Cys-111 increases
the proportion of highly fibrylogenic hSOD1 monomers (61,
62). Indeed, removal of Cys-111 reduces the formation of aggre-
gates (17, 57, 63). Our novel assay probes directly the reactivity
of the key Cys-111. We find that Cys-111 is highly reactive
against the disulfide in the unfolded state of hSOD1. We spec-
ulate that isomerization reactions in hSOD1 could be triggered
in vivo following rare unfolding events induced by thermal fluc-
tuations, or as a consequence of mechanical unfolding during
translocation into the intermembrane space of mitochondria.
We show that in disease-linked hSOD1 mutants, the reactiv-
ity pattern of Cys-111 and the conserved disulfide is altered.
Thiol/disulfide exchange reactions originating at Cys-111 are
deeply perturbed in hSOD1 G93A, enhancing the regioselective
attack on Cys-146 and decreasing the overall reactivity of Cys-
111. Interestingly, oxidation of Cys-111 is favored in murine
models of ALS that express hSOD1 G93A (64). We hypothesize
that in hSOD1 G93A, Cys-111 becomes more sensitive to redox
modifications, probably because of increased solvent accessi-
bility. This increased exposure to the solvent may lead to inter-
molecular thiol/disulfide exchange reactions and aggregation
(15, 26, 38). It is also possible that structural perturbations
caused by the mutation result in decreased reactivity of Cys-111
(54) (53). Remarkably, our results show that the structural con-
straints introduced by the addition of a single methyl group to a
distant residue can be enough to significantly bias intramolec-
ular reactions. Such alteration of reactivity could result in the
accumulation of one kind of non-native disulfides, which may
contribute to the gain of toxic function that leads to ALS.
We did not observe any signature originating from the disulfide
in hSOD1 A4V, strongly suggesting that the bond is exposed to the
solvent and is readily cleaved by the reducing agent before the
molecule can be probed by the AFM. Our results suggest that
the A4V mutation may perturb the structure of hSOD1, render-
ing the disulfide more sensitive to reduction and accelerating
misfolding and aggregation of the protein (37, 39). In agree-
ment with this view, high-resolution structural studies have
concluded that there is significant structural destabilization
associated with the A4V mutation in hSOD1 (65, 66).
It remains unknown why many apparently unrelated mutations
in hSOD1 converge in the ALS phenotype (9, 11). Our novel force-
clamp assay can be used to systematically examine the thiol/disul-
fide chemistry of diseased-linked forms of hSOD1, as done here for
A4V and G93A, to gain a deeper understanding of the molecular
pathogenesis of ALS. Here, we have found that A4V and G93A
showed different reactivity patterns from wild-type protein. It will
be interesting to examine whether other hSOD1 variants share
the same reactivity profiles.
Our results suggest that conformational changes associated
with mutations A4V and G93A cause changes in the thiol
chemistry of hSOD, which could favor misfolding and aggrega-
tion through formation of non-native inter- and intramolecular
disulfide bonds. We propose that wild-type hSOD1 may occa-
sionally sample those toxic conformations, maybe accounting
for some forms of sporadic ALS. We show, at the single-mole-
cule level, evidence that the disulfide bond of monomeric
hSOD1 is susceptible to isomerization. The isomerization reac-
tions are strongly affected by the mutations A4V and G93A.
Since the isomerization reaction competes with the intermo-
lecular reduction of the disulfide by redox metabolites, the
extent of isomerization reactions is predicted to be sensitive to
the redox state of motoneurons. During translocation to the
intermembrane space of mitochondria, the reduced cysteine
residues in hSOD1 experiences a more oxidizing environment
than in the cytosol. We therefore speculate that mitochondria
may be hot spots in which hSOD1, and especially diseased-
linked mutants, become misfolded and prone to oligomerize.
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